Vanguard Group
HSCS icon

Vanguard Group’s Heart Test Laboratories HSCS Stock Holding History

Vanguard Group’s Portfolio HSCS Stock Details HSCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$57.3K Hold
18,556
– – ﹤0.01% 4226
2025
Q3 		$64.6K Buy
+18,556
New +$67.5K ﹤0.01% 4266
2024
Q2 		– Sell
-1,915
Closed -$22.4K – 4423
2024
Q1 		$22.4K Buy
1,915
+159
+9% +$2.08K ﹤0.01% 4386
2023
Q4 		$30K Buy
+1,756
New +$43.3K ﹤0.01% 4415

Other funds holding HSCS

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
TA
TFB Advisors Overland Park, Kansas $191M AUM 18.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ASW
Astoria Strategic Wealth Conroe, Texas $438M AUM 16.79% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Group's HSCS Position: Q4 2025 in Review

Vanguard Group held its Heart Test Laboratories (HSCS) position steady in Q4 2025 at 18,556 shares worth $57.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4226.

Vanguard Group first reported a position in HSCS in Q4 2023 and has held it in 4 quarters since. The position peaked at $64.6K in Q3 2025. 10 funds tracked by Wall St. Rank hold HSCS as of Q4 2025.

  • Vanguard Group held 18,556 shares of Heart Test Laboratories worth $57.3K as of Q4 2025.
  • Vanguard Group left its Heart Test Laboratories share count unchanged in Q4 2025.
  • Heart Test Laboratories made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4226 holding.
  • Vanguard Group first reported a position in Heart Test Laboratories in Q4 2023 and has held it in 4 quarters since.
  • Vanguard Group's Heart Test Laboratories position peaked at $64.6K in Q3 2025.
  • 10 funds tracked by Wall St. Rank held Heart Test Laboratories as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.